| pubmed-article:15298638 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15298638 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:15298638 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:15298638 | lifeskim:mentions | umls-concept:C0014822 | lld:lifeskim |
| pubmed-article:15298638 | lifeskim:mentions | umls-concept:C0032181 | lld:lifeskim |
| pubmed-article:15298638 | lifeskim:mentions | umls-concept:C0023891 | lld:lifeskim |
| pubmed-article:15298638 | lifeskim:mentions | umls-concept:C0836924 | lld:lifeskim |
| pubmed-article:15298638 | lifeskim:mentions | umls-concept:C0599724 | lld:lifeskim |
| pubmed-article:15298638 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:15298638 | pubmed:dateCreated | 2004-8-9 | lld:pubmed |
| pubmed-article:15298638 | pubmed:abstractText | Patients with liver cirrhosis have a complex haemostasis disturbance including thrombocytopenia and abnormal bleeding time. Erythropoietin is the primary stimulator for erythrocyte production and also induces megakaryocyte formation. In healthy men erythropoietin increased platelet count and platelet reactivity. | lld:pubmed |
| pubmed-article:15298638 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15298638 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15298638 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15298638 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15298638 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15298638 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:15298638 | pubmed:issn | 0269-2813 | lld:pubmed |
| pubmed-article:15298638 | pubmed:author | pubmed-author:SchmidMM | lld:pubmed |
| pubmed-article:15298638 | pubmed:author | pubmed-author:FerlitschAA | lld:pubmed |
| pubmed-article:15298638 | pubmed:author | pubmed-author:Peck-Radosavl... | lld:pubmed |
| pubmed-article:15298638 | pubmed:author | pubmed-author:HomoncikMM | lld:pubmed |
| pubmed-article:15298638 | pubmed:author | pubmed-author:Jilma-Stohlaw... | lld:pubmed |
| pubmed-article:15298638 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15298638 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:15298638 | pubmed:volume | 20 | lld:pubmed |
| pubmed-article:15298638 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15298638 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15298638 | pubmed:pagination | 437-43 | lld:pubmed |
| pubmed-article:15298638 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15298638 | pubmed:meshHeading | pubmed-meshheading:15298638... | lld:pubmed |
| pubmed-article:15298638 | pubmed:meshHeading | pubmed-meshheading:15298638... | lld:pubmed |
| pubmed-article:15298638 | pubmed:meshHeading | pubmed-meshheading:15298638... | lld:pubmed |
| pubmed-article:15298638 | pubmed:meshHeading | pubmed-meshheading:15298638... | lld:pubmed |
| pubmed-article:15298638 | pubmed:meshHeading | pubmed-meshheading:15298638... | lld:pubmed |
| pubmed-article:15298638 | pubmed:meshHeading | pubmed-meshheading:15298638... | lld:pubmed |
| pubmed-article:15298638 | pubmed:meshHeading | pubmed-meshheading:15298638... | lld:pubmed |
| pubmed-article:15298638 | pubmed:meshHeading | pubmed-meshheading:15298638... | lld:pubmed |
| pubmed-article:15298638 | pubmed:meshHeading | pubmed-meshheading:15298638... | lld:pubmed |
| pubmed-article:15298638 | pubmed:meshHeading | pubmed-meshheading:15298638... | lld:pubmed |
| pubmed-article:15298638 | pubmed:meshHeading | pubmed-meshheading:15298638... | lld:pubmed |
| pubmed-article:15298638 | pubmed:meshHeading | pubmed-meshheading:15298638... | lld:pubmed |
| pubmed-article:15298638 | pubmed:meshHeading | pubmed-meshheading:15298638... | lld:pubmed |
| pubmed-article:15298638 | pubmed:meshHeading | pubmed-meshheading:15298638... | lld:pubmed |
| pubmed-article:15298638 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15298638 | pubmed:articleTitle | Erythropoietin increases platelet reactivity and platelet counts in patients with alcoholic liver cirrhosis: a randomized, double-blind, placebo-controlled study. | lld:pubmed |
| pubmed-article:15298638 | pubmed:affiliation | Clinical Pharmacology-TARGET, Vienna University School of Medicine, Wien, Austria. monika.homoncik@univie.ac.at | lld:pubmed |
| pubmed-article:15298638 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15298638 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:15298638 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:15298638 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15298638 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15298638 | lld:pubmed |
